Discovering Therapeutic Advantage
Through Innovations in Drug Delivery

OINDPs

Discovering Therapeutic Advantage
Through Innovations in Drug Delivery

Kenox is a niche player in orally inhaled and nasal drug products (OINDPs) development, from molecule to finished product  

Our leadership team has over 25 years of experience in intranasal and inhaled drug product development of a variety of device technology platforms including DPIs, Soft mist inhalers, Nebulizers, and pMDIs of small as well as biologic molecules. The team also has in-depth knowledge of solubilization technologies, particle engineering technologies, and solid-state chemistry.

Please reach out to bd@kenoxpharma.us to learn more about our expertise, capabilities, or partnering opportunities.